General Discussions

Jose Lutzky on Proactively Monitoring Patients Receiving Immunotherapy Treatments

By Jose Lutzky, MD
PUBLISHED THURSDAY, JANUARY 1, 1970

Jose Lutzky, MD, from Mount Sinai Medical Center, discusses the best practices for monitoring patients on immunotherapy.

With treatments that are potentially very toxic, it is important to develop a plan for following up with the patients. Every patient is different and some will need closer monitoring than others. Nurses shouldn’t rely on the patient to reach out to them, either. For treatments that could possibly result in these kinds of adverse events, it is better to take a more proactive approach to patient monitoring.

Start a discussion
You must log in to use this feature, please click here to login.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.